European Journal of Epidemiology

, Volume 34, Issue 8, pp 731–752 | Cite as

Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers

  • Youngyo Kim
  • Youjin JeEmail author
  • Edward Giovannucci


Coffee consumption has been associated with decreased mortality in previous studies. As aging, obesity, and lifestyle factors affect the risk of mortality, the association between coffee and mortality needs to be examined in various subpopulations by characteristics of subjects. To quantitatively assess this association, we conducted an updated meta-analysis including stratified analyses by potential modifiers. We searched in the PubMed and Web of Science databases through March 8, 2019, and conducted meta-analysis including linear and non-linear dose–response analyses. We identified 40 studies including 3,852,651 subjects and 450,256 all-cause and cause-specific deaths. Non-linear inverse associations between coffee consumption and mortality from all-causes, cardiovascular disease (CVD), and cancers were found. The lowest relative risk (RR) was at intakes of 3.5 cups/day for all-cause mortality (RR = 0.85, 95% CI 0.82–0.89), 2.5 cups/day for CVD mortality (RR = 0.83, 95% CI 0.80–0.87), and 2 cups/day for cancer mortality (RR = 0.96, 95% CI 0.94–0.99), while additional intakes were not associated with further lower mortality. An inverse association between coffee consumption and all-cause mortality was maintained irrespective of age, overweight status, alcohol drinking, smoking status, and caffeine content of coffee. By region, Europe and Asia showed stronger inverse associations than US. A non-linear inverse association was found for mortality from respiratory disease and diabetes, while linear inverse association was found for mortality from non-CVD, non-cancer causes. Moderate coffee consumption (e.g. 2–4 cups/day) was associated with reduced all-cause and cause-specific mortality, compared to no coffee consumption. The inverse association between coffee and all-cause mortality was consistent by potential modifiers except region.


Coffee Mortality Meta-analysis Age BMI Alcohol consumption 



This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education (NRF-2017R1A6A3A01075728) and by the Ministry of Science, ICT and Future Planning (NRF-2018R1D1A1B07045353). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10654_2019_524_MOESM1_ESM.docx (54 kb)
Supplementary material 1 (DOCX 54 kb)


  1. 1.
    Jeszka-Skowron M, Zgola-Grzeskowiak A, Grzeskowiak T. Analytical methods applied for the characterization and the determination of bioactive compounds in coffee. Eur Food Res Technol. 2015;240(1):19–31.CrossRefGoogle Scholar
  2. 2.
    Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens. 2005;23(5):921–8.CrossRefGoogle Scholar
  3. 3.
    Hong X, Xu Q, Lan K, Huang H, Zhang Y, Chen S, et al. The effect of daily fluid management and beverages consumption on the risk of bladder cancer: a meta-analysis of observational study. Nutr Cancer. 2018;1:1–11. Scholar
  4. 4.
    Wu W, Tong Y, Zhao Q, Yu G, Wei X, Lu Q. Coffee consumption and bladder cancer: a meta-analysis of observational studies. Sci Rep. 2015;5:9051. Scholar
  5. 5.
    Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol. 2016;17(7):877–8. Scholar
  6. 6.
    Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 2017;37:131–56. Scholar
  7. 7.
    Andersen LF, Jacobs DR Jr, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women’s Health Study. Am J Clin Nutr. 2006;83(5):1039–46.CrossRefGoogle Scholar
  8. 8.
    Ding M, Satija A, Bhupathiraju SN, Hu Y, Sun Q, Han J, et al. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. 2015;132(24):2305–15. Scholar
  9. 9.
    Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med. 2012;366(20):1891–904. Scholar
  10. 10.
    Gapstur SM, Anderson RL, Campbell PT, Jacobs EJ, Hartman TJ, Hildebrand JS, et al. Associations of coffee drinking and cancer mortality in the cancer prevention study-II. Cancer Epidemiol Biomark Prev. 2017;26(10):1477–86. Scholar
  11. 11.
    Gardener H, Rundek T, Wright CB, Elkind MS, Sacco RL. Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population. J Nutr. 2013;143(8):1299–308. Scholar
  12. 12.
    Grosso G, Stepaniak U, Micek A, Stefler D, Bobak M, Pajak A. Coffee consumption and mortality in three Eastern European countries: results from the HAPIEE (Health, Alcohol and Psychosocial factors In Eastern Europe) study. Public Health Nutr. 2017;20(1):82–91. Scholar
  13. 13.
    Gunter MJ, Murphy N, Cross AJ, Dossus L, Dartois L, Fagherazzi G, et al. Coffee drinking and mortality in 10 European Countries: a multinational cohort study. Ann Intern Med. 2017;167(4):236–47. Scholar
  14. 14.
    Happonen P, Laara E, Hiltunen L, Luukinen H. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. Br J Nutr. 2008;99(6):1354–61. Scholar
  15. 15.
    Hart C, Smith GD. Coffee consumption and coronary heart disease mortality in Scottish men: a 21 year follow up study. J Epidemiol Community Health. 1997;51(4):461–2.CrossRefGoogle Scholar
  16. 16.
    Iwai N, Ohshiro H, Kurozawa Y, Hosoda T, Morita H, Funakawa K, et al. Relationship between coffee and green tea consumption and all-cause mortality in a cohort of a rural Japanese population. J Epidemiol. 2002;12(3):191–8.CrossRefGoogle Scholar
  17. 17.
    Jacobsen BK, Bjelke E, Kvale G, Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst. 1986;76(5):823–31.PubMedGoogle Scholar
  18. 18.
    Jazbec A, Simic D, Corovic N, Durakovic Z, Pavlovic M. Impact of coffee and other selected factors on general mortality and mortality due to cardiovascular disease in Croatia. J Health Popul Nutr. 2003;21(4):332–40.PubMedGoogle Scholar
  19. 19.
    Kahn HA, Phillips RL, Snowdon DA, Choi W. Association between reported diet and all-cause mortality. Twenty-one-year follow-up on 27,530 adult Seventh-Day Adventists. Am J Epidemiol. 1984;119(5):775–87.CrossRefGoogle Scholar
  20. 20.
    Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and mortality. Ann Epidemiol. 1993;3(4):375–81.CrossRefGoogle Scholar
  21. 21.
    Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med. 2000;160(22):3393–400.CrossRefGoogle Scholar
  22. 22.
    LeGrady D, Dyer AR, Shekelle RB, Stamler J, Liu K, Paul O, et al. Coffee consumption and mortality in the Chicago Western Electric Company Study. Am J Epidemiol. 1987;126(5):803–12.CrossRefGoogle Scholar
  23. 23.
    Lim WH, Wong G, Lewis JR, Lok CE, Polkinghorne KR, Hodgson J, et al. Total volume and composition of fluid intake and mortality in older women: a cohort study. BMJ Open. 2017;7(3):e011720. Scholar
  24. 24.
    Lindsted KD, Kuzma JW, Anderson JL. Coffee consumption and cause-specific mortality. Association with age at death and compression of mortality. J Clin Epidemiol. 1992;45(7):733–42.CrossRefGoogle Scholar
  25. 25.
    Liu J, Sui X, Lavie CJ, Hebert JR, Earnest CP, Zhang J, et al. Association of coffee consumption with all-cause and cardiovascular disease mortality. Mayo Clin Proc. 2013;88(10):1066–74. Scholar
  26. 26.
    Lof M, Sandin S, Yin L, Adami HO, Weiderpass E. Prospective study of coffee consumption and all-cause, cancer, and cardiovascular mortality in Swedish women. Eur J Epidemiol. 2015;30(9):1027–34. Scholar
  27. 27.
    Loftfield E, Freedman ND, Graubard BI, Guertin KA, Black A, Huang WY, et al. Association of coffee consumption with overall and cause-specific mortality in a large us prospective cohort study. Am J Epidemiol. 2015;182(12):1010–22. Scholar
  28. 28.
    Loomba RS, Aggarwal S, Arora RR. The effect of coffee and quantity of consumption on specific cardiovascular and all-cause mortality: coffee consumption does not affect mortality. Am J Ther. 2016;23(1):e232–7. Scholar
  29. 29.
    Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, et al. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health. 2011;65(3):230–40. Scholar
  30. 30.
    Nordestgaard AT, Nordestgaard BG. Coffee intake, cardiovascular disease and all-cause mortality: observational and Mendelian randomization analyses in 95 000-223 000 individuals. Int J Epidemiol. 2016;45(6):1938–52. Scholar
  31. 31.
    Odegaard AO, Koh WP, Yuan JM, Pereira MA. Beverage habits and mortality in Chinese adults. J Nutr. 2015;145(3):595–604. Scholar
  32. 32.
    Paganini-Hill A, Kawas CH, Corrada MM. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med. 2007;44(4):305–10. Scholar
  33. 33.
    Park SY, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR, Setiawan VW. Association of coffee consumption with total and cause-specific mortality among nonwhite populations. Ann Intern Med. 2017;167(4):228–35. Scholar
  34. 34.
    Rosengren A, Wilhelmsen L. Coffee, coronary heart disease and mortality in middle-aged Swedish men: findings from the Primary Prevention Study. J Intern Med. 1991;230(1):67–71.CrossRefGoogle Scholar
  35. 35.
    Saito E, Inoue M, Sawada N, Shimazu T, Yamaji T, Iwasaki M, et al. Association of coffee intake with total and cause-specific mortality in a Japanese population: the Japan Public Health Center-based Prospective Study. Am J Clin Nutr. 2015;101(5):1029–37. Scholar
  36. 36.
    Sugiyama K, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Ohmori-Matsuda K, et al. Coffee consumption and mortality due to all causes, cardiovascular disease, and cancer in Japanese women. J Nutr. 2010;140(5):1007–13. Scholar
  37. 37.
    Tamakoshi A, Lin Y, Kawado M, Yagyu K, Kikuchi S, Iso H, et al. Effect of coffee consumption on all-cause and total cancer mortality: findings from the JACC study. Eur J Epidemiol. 2011;26(4):285–93. Scholar
  38. 38.
    van den Brandt PA. Coffee or Tea? A prospective cohort study on the associations of coffee and tea intake with overall and cause-specific mortality in men versus women. Eur J Epidemiol. 2018. Scholar
  39. 39.
    Vandenbroucke JP, Kok FJ, van ‘t Bosch G, van den Dungen PJ, van der Heide-Wessel C, van der Heide RM. Coffee drinking and mortality in a 25-year follow up. Am J Epidemiol. 1986;123(2):359–61.CrossRefGoogle Scholar
  40. 40.
    Woodward M, Tunstall-Pedoe H. Coffee and tea consumption in the Scottish Heart Health Study follow up: conflicting relations with coronary risk factors, coronary disease, and all cause mortality. J Epidemiol Community Health. 1999;53(8):481–7.CrossRefGoogle Scholar
  41. 41.
    Sado J, Kitamura T, Kitamura Y, Sobue T, Nishino Y, Tanaka H, et al. Association between coffee consumption and all-sites cancer incidence and mortality. Cancer Sci. 2017;108(10):2079–87. Scholar
  42. 42.
    Torres-Collado L, Garcia-de-la-Hera M, Navarrete-Munoz EM, Notario-Barandiaran L, Gonzalez-Palacios S, Zurriaga O, et al. Coffee consumption and mortality from all causes of death, cardiovascular disease and cancer in an elderly Spanish population. Eur J Nutr. 2018. Scholar
  43. 43.
    Loftfield E, Cornelis MC, Caporaso N, Yu K, Sinha R, Freedman N. Association of coffee drinking with mortality by genetic variation in caffeine metabolism: findings from the UK Biobank. JAMA Intern Med. 2018;178(8):1086–97. Scholar
  44. 44.
    Sado J, Kitamura T, Kitamura Y, Liu R, Ando E, Sobue T, et al. Coffee consumption and all-cause and cardiovascular mortality-Three-Prefecture Cohort in Japan. Circ J. 2019. Scholar
  45. 45.
    Navarro AM, Martinez-Gonzalez MA, Gea A, Grosso G, Martin-Moreno JM, Lopez-Garcia E, et al. Coffee consumption and total mortality in a Mediterranean prospective cohort. Am J Clin Nutr. 2018;108(5):1113–20. Scholar
  46. 46.
    Kohlmeier L, Mensink G, Kohlmeier M. The relationship between coffee consumption and lipid levels in young and older people in the Heidelberg-Michelstadt-Berlin study. Eur Heart J. 1991;12(8):869–74.CrossRefGoogle Scholar
  47. 47.
    Arciero PJ, Ormsbee MJ. Relationship of blood pressure, behavioral mood state, and physical activity following caffeine ingestion in younger and older women. Appl Physiol Nutr Metab. 2009;34(4):754–62. Scholar
  48. 48.
    Bracco D, Ferrarra JM, Arnaud MJ, Jequier E, Schutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol. 1995;269(4 Pt 1):E671–8. Scholar
  49. 49.
    Acheson KJ, Zahorska-Markiewicz B, Pittet P, Anantharaman K, Jequier E. Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr. 1980;33(5):989–97. Scholar
  50. 50.
    Grosso G, Micek A, Godos J, Sciacca S, Pajak A, Martinez-Gonzalez MA, et al. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. Eur J Epidemiol. 2016;31(12):1191–205. Scholar
  51. 51.
    Je Y, Giovannucci E. Coffee consumption and total mortality: a meta-analysis of twenty prospective cohort studies. Br J Nutr. 2014;111(7):1162–73. Scholar
  52. 52.
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRefGoogle Scholar
  53. 53.
    Wells GA SB, O’Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Accessed 2 May 2019.
  54. 54.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.CrossRefGoogle Scholar
  55. 55.
    Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993;4(3):218–28.CrossRefGoogle Scholar
  56. 56.
    Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301–9.CrossRefGoogle Scholar
  57. 57.
    Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6(1):40–57.CrossRefGoogle Scholar
  58. 58.
    Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66–73. Scholar
  59. 59.
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.CrossRefGoogle Scholar
  60. 60.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.CrossRefGoogle Scholar
  61. 61.
    Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 2014;180(8):763–75. Scholar
  62. 62.
    Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr. 2014;53(1):25–38. Scholar
  63. 63.
    Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643–59. Scholar
  64. 64.
    van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA. 2005;294(1):97–104. Scholar
  65. 65.
    Cornelis MC, Kacprowski T, Menni C, Gustafsson S, Pivin E, Adamski J, et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet. 2016;25(24):5472–82. Scholar
  66. 66.
    Nightingale CM, Rudnicka AR, Owen CG, Wells JC, Sattar N, Cook DG, et al. Influence of adiposity on insulin resistance and glycemia markers among U.K. Children of South Asian, black African-Caribbean, and white European origin: child heart and health study in England. Diabetes Care. 2013;36(6):1712–9. Scholar
  67. 67.
    Elsamadony A, Yates KF, Sweat V, Yau PL, Mangone A, Joseph A, et al. Asian adolescents with excess weight are at higher risk for insulin resistance than Non-Asian Peers. Obesity (Silver Spring). 2017;25(11):1974–9. Scholar
  68. 68.
    Alfaro TM, Monteiro RA, Cunha RA, Cordeiro CR. Chronic coffee consumption and respiratory disease: a systematic review. Clin Respir J. 2018;12(3):1283–94. Scholar
  69. 69.
    Carlstrom M, Larsson SC. Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev. 2018;76(6):395–417. Scholar
  70. 70.
    Kang D, Kim Y, Je Y. Non-alcoholic beverage consumption and risk of depression: epidemiological evidence from observational studies. Eur J Clin Nutr. 2018;72(11):1506–16. Scholar
  71. 71.
    Lucas M, O’Reilly EJ, Pan A, Mirzaei F, Willett WC, Okereke OI, et al. Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults. World J Biol Psychiatry. 2014;15(5):377–86. Scholar
  72. 72.
    Schottker B, Saum KU, Jansen EH, Boffetta P, Trichopoulou A, Holleczek B, et al. Oxidative stress markers and all-cause mortality at older age: a population-based cohort study. J Gerontol A Biol Sci Med Sci. 2015;70(4):518–24. Scholar
  73. 73.
    Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–9. Scholar
  74. 74.
    Liang N, Kitts DD. Antioxidant property of coffee components: assessment of methods that define mechanisms of action. Molecules. 2014;19(11):19180–208. Scholar
  75. 75.
    Hoelzl C, Knasmuller S, Wagner KH, Elbling L, Huber W, Kager N, et al. Instant coffee with high chlorogenic acid levels protects humans against oxidative damage of macromolecules. Mol Nutr Food Res. 2010;54(12):1722–33. Scholar
  76. 76.
    Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C. Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem. 2002;50(21):6211–6.CrossRefGoogle Scholar
  77. 77.
    Misik M, Hoelzl C, Wagner KH, Cavin C, Moser B, Kundi M, et al. Impact of paper filtered coffee on oxidative DNA-damage: results of a clinical trial. Mutat Res. 2010;692(1–2):42–8. Scholar
  78. 78.
    Hori A, Kasai H, Kawai K, Nanri A, Sato M, Ohta M, et al. Coffee intake is associated with lower levels of oxidative DNA damage and decreasing body iron storage in healthy women. Nutr Cancer. 2014;66(6):964–9. Scholar
  79. 79.
    Williams CJ, Fargnoli JL, Hwang JJ, van Dam RM, Blackburn GL, Hu FB, et al. Coffee consumption is associated with higher plasma adiponectin concentrations in women with or without type 2 diabetes: a prospective cohort study. Diabetes Care. 2008;31(3):504–7. Scholar
  80. 80.
    Zhang Y, Zhang DZ. Is coffee consumption associated with a lower level of serum C-reactive protein? A meta-analysis of observational studies. Int J Food Sci Nutr. 2018. Scholar
  81. 81.
    Hang D, Kvaerner AS, Ma W, Hu Y, Tabung FK, Nan H, et al. Coffee consumption and plasma biomarkers of metabolic and inflammatory pathways in US health professionals. Am J Clin Nutr. 2019;109(3):635–47. Scholar
  82. 82.
    Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr. 2010;91(4):950–7. Scholar
  83. 83.
    Zhang Y, Zhang DZ. Associations of coffee consumption with circulating level of adiponectin and leptin. A meta-analysis of observational studies. Int J Food Sci Nutr. 2018. Scholar
  84. 84.
    Li Q, Liu Y, Sun X, Yin Z, Li H, Cheng C, et al. Caffeinated and decaffeinated coffee consumption and risk of all-cause mortality: a dose-response meta-analysis of cohort studies. J Hum Nutr Diet. 2019. Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Food and NutritionKyung Hee UniversitySeoulSouth Korea
  2. 2.Departments of Nutrition and EpidemiologyHarvard TH Chan School of Public HealthBostonUSA

Personalised recommendations